Chemed CORP Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
AQR Capital Management, through its entities, now beneficially owns 7.25% of Chemed Corp's capital stock, reporting shared voting and dispositive power over a significant portion of these shares.
NYSE
Vanguard Capital Management has disclosed beneficial ownership of 5.4% of Chemed Corp's common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.93% in Chemed Corp's common stock as of March 31, 2026.